Caution should be exercised when administering insulin to elderly patients. In elderly patients with diabetes, dosing should be conservative to avoid hypoglycemia. Hypoglycemia is the most common adverse effect of insulin, including Lantus®. Hypoglycemia may be difficult to recognize in the elderly.
A tailored approach is recommended
Consider less stringent glycemic goals for frail older residents or those with the following conditions1:
As type 2 diabetes progresses, many LTC residents will require insulin to manage their disease.
A basal-prandial regimen significantly reduced BG vs SSI monotherapy in the RABBIT 2 Study.
See how Lantus® provides effective, improved glycemic control in diabetes patients.†
†Lantus® Prescribing Information. August 2015.
Lantus® is a once-daily, long-acting insulin.**
**Lantus® Prescribing Information. August 2015.
Lantus® is a basal insulin with demonstrated long-term CV safety data††